0000921895-22-000661.txt : 20220224 0000921895-22-000661.hdr.sgml : 20220224 20220224201341 ACCESSION NUMBER: 0000921895-22-000661 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220222 FILED AS OF DATE: 20220224 DATE AS OF CHANGE: 20220224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Giordano Natasha CENTRAL INDEX KEY: 0001315585 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36351 FILM NUMBER: 22673817 MAIL ADDRESS: STREET 1: 8285 EL RIO STREET STREET 2: SUITE 130 CITY: HOUSTON STATE: TX ZIP: 77054 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PLx Pharma Inc. CENTRAL INDEX KEY: 0001497504 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271707962 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9 FISHERS LANE STREET 2: SUITE E CITY: SPARTA STATE: NJ ZIP: 07871 BUSINESS PHONE: (713) 842-1249 MAIL ADDRESS: STREET 1: 9 FISHERS LANE STREET 2: SUITE E CITY: SPARTA STATE: NJ ZIP: 07871 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20140313 FORMER COMPANY: FORMER CONFORMED NAME: Dipexium Pharmaceuticals, LLC DATE OF NAME CHANGE: 20100726 4 1 form411577gio_02242022.xml OWNERSHIP DOCUMENT X0306 4 2022-02-22 0 0001497504 PLx Pharma Inc. PLXP 0001315585 Giordano Natasha 9 FISHERS LANE SUITE E SPARTA NJ 07871 1 1 0 0 Chief Executive Officer Stock Option (right to buy) 4.99 2022-02-22 4 A 0 300000 0 A 2032-02-22 Common Stock 300000 300000 D Grant of stock options to the Reporting Person under the Issuer's 2018 Incentive Plan, as amended. These stock options vest over a three year period as follows: 1/3 on the first anniversary of the grant date, 1/3 on the second anniversary of the grant date and 1/3 on the third anniversary of the grant date. /s/ Natasha Giordano 2022-02-23